Episode 451: Meet the 2026 Winner of the John Dystel Prize for MS Research with Dr. Ludwig Kappos
The annual meeting of the American Academy of Neurology is underway in Chicago this week, and one of the highlights is the presentation of the John Dystel Prize for Research in Multiple Sclerosis, awa...
20 Apr 32min
Episode 450: Exercise is Medicine for People with MS with Dr. Robert Motl
An exercise program can be hard to start and even more difficult to stick with. But the evidence-based benefits speak for themselves. For people living with MS, it can mean improving quality of life w...
13 Apr 33min
Episode 449: Putting People Affected by MS at the Center of MS Research with Sara Loud, Stephanie Buxhoeveden, and Hollie Schmidt
When you join the iConquer MS community, you're no longer just a patient; you become a research partner. Not just a data point in someone's study. You become the person to suggest the study, to help d...
6 Apr 37min
Episode 448: At the National MS Society's Public Policy Conference with David, Cliff, and Michelle
Last week, about 170 MS activists from across the country gathered in Washington, D.C. to participate in the National MS Society's Public Policy Conference. It's hard to come away from this event and ...
30 Mars 31min
Episode 447: Walking with Many Sisters Toward a Cure with Brigitte Delaney
In 1988, there were just 42 Walk MS events, raising approximately $4 million. In 2025, there were 170 events across the country that raised over $30 million. As the largest private funder of MS resear...
23 Mars 23min
Episode 445: It's MS Awareness Week with Kristine Werner Ozug and Kim, Kim, and Kim
It's MS Awareness Week, and this year we're diving into a theme that hits home for millions: Unseen MS. Multiple sclerosis is a master of disguise; it can be entirely invisible to the naked eye while ...
9 Mars 40min
Episode 444: Treating MS with a GLP-1 with Dr. Ellen Mowry
You know them by their trade names such as Ozempic, Wegovy, Mounjaro, and Zepbound. This class of medications is known as GLP-1 receptor agonists. And while they are best known for managing diabetes a...
2 Mars 31min
